Usefulness of fecal calprotectin by monoclonal antibody testing in adult Japanese with inflammatory bowel diseases: a prospective multicenter study
Background/Aims Noninvasive objective monitoring is advantageous for optimizing treatment strategies in patients inflammatory bowel disease (IBD). Fecal calprotectin (FCP) is superior to traditional biomarkers in terms of assessing the activity in patients with IBD. However, there are the difference...
Main Authors: | Shiro Nakamura, Hirotsugu Imaeda, Hiroki Nishikawa, Masaki Iimuro, Minoru Matsuura, Hideo Oka, Junsuke Oku, Takako Miyazaki, Hirohito Honda, Kenji Watanabe, Hiroshi Nakase, Akira Andoh |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Association for the Study of Intestinal Diseases
2018-10-01
|
Series: | Intestinal Research |
Subjects: | |
Online Access: | http://www.irjournal.org/upload/pdf/ir-2018-00027.pdf |
Similar Items
-
Fecal Calprotectin in Inflammatory Bowel Disease
by: Jun Lee
Published: (2016-05-01) -
The role of fecal calprotectin in pediatric disease
by: Su Jin Jeong
Published: (2019-08-01) -
Fecal calprotectin in inflammatory bowel disease
by: Walsham NE, et al.
Published: (2016-01-01) -
Fecal calprotectin concentration in neonatal necrotizing enterocolitis
by: Jung Min Yoon, et al.
Published: (2014-08-01) -
Fecal calprotectin is associated with disease activity in patients with ankylosing spondylitis
by: Arzu Duran, et al.
Published: (2016-01-01)